AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%
September 03, 2021 16:15 ET
|
Anpac Bio, USA
PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...
AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists
August 30, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...
AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements
October 07, 2020 07:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Receives Major Immunology Testing Contract
September 15, 2020 07:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification
August 24, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...